ORPHA:206575
Rippling muscle disease with myasthenia gravis
Also called Acquired rippling muscle disease, Immune-mediated rippling muscle disease
- Body system
- Neurological diseases
- Inheritance pattern
- Not applicable
- Typical age of onset
- Not documented in Orphadata
- Estimated prevalence
- Not documented in Orphadata
- Rarity class
- Not documented in Orphadata
About this disease
Rippling muscle disease with myasthenia gravis is a rare, acquired, neuromuscular disease characterized by CAV3 mutation-negative rippling muscle disease in association with acetylcholine receptor antibody-mediated myasthenia gravis. Patients typically present exercise-induced, electrically-silent muscle rippling with myalgia, in combination with generalized myasthenia gravis symptoms (ptosis, diplopia, neck weakness, dysphagia and dyspnea).
Definition from Orphanet.
Learn more
Source: Orphanet (Orphadata), ORPHA:206575. Data release 2026-06-23. www.orphadata.com — CC BY 4.0.